Curis Inc
CRIS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001108205
No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Curis Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Curis Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Rubin Marc | Director | 28,108 | Jul 9, 2026 | 3 |
| Kaitin Kenneth I | Director | 11,407 | Jul 9, 2026 | 2 |
| Hohneker John | Director | – | Jul 9, 2026 | 1 |
| Greenacre Martyn D | Director | – | Jul 9, 2026 | 1 |
| Borgman Anne Elizabeth | Director | – | Jul 9, 2026 | 1 |
| Duvall Diantha | CFO | 77,707 | Jul 9, 2026 | 3 |
| Zung Jonathan B. | CDO | 66,667 | Jul 9, 2026 | 3 |
| Dentzer James E | President & CEO | 148,730 | Jul 9, 2026 | 3 |
| Hamdy Ahmed MD | CMO | 66,667 | Mar 23, 2026 | 2 |
| Martell Robert | Head of Research & Development | – | Jan 24, 2023 | 0 |
| Kunkel Lori Anne | Director | – | Jan 31, 2022 | 0 |
| Steinkrauss William | Chief Financial Officer | – | Jan 31, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Kaitin Kenneth IDirector | PPurchase | +10.0K | $0.55 | +$5.50K | +710.7%11.4K after | |
| Jan 31, 2022 (view filing) | Jan 27-31 | 4 days | Dentzer James EPresident & CEO | SSale | −5.50K | $3.12 | −$17.1K | −7.8%64.9K after | 2 lots |